SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-158650
Filing Date
2016-11-22
Accepted
2016-11-22 17:11:58
Documents
4
Period of Report
2016-11-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-19529_68k.htm 8-K 35081
2 EX-1.1 a16-19529_6ex1d1.htm EX-1.1 245964
3 EX-4.1 a16-19529_6ex4d1.htm EX-4.1 99839
4 EX-99.1 a16-19529_6ex99d1.htm EX-99.1 10341
  Complete submission text file 0001104659-16-158650.txt   392435
Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address 1098 HAMILTON COURT MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 162014020
SIC: 2834 Pharmaceutical Preparations